Market Insights
The bioresorbable polymers market size value was US$560 million in 2025 and is likely to grow at a robust CAGR of 12% in the long run to reach US$1.1 billion in 2031.”
Market Dynamics
Introduction
Bioresorbable polymers are engineered materials that, within the intended application, can physically break apart and be absorbed within the body. Absorbable polymers conserve biocompatibility, develop controlled degradation, and mechanical strength, excellent for medical usage. These polymers are greatly utilized in orthopedic fixation, sutures, cardiovascular stents, and systems requiring controlled drug delivery devices.
The growing focus on developing bioresorbable polymers has revolutionized the MedTech device world. There is a growing focus on performing minimally invasive procedures, developing tissue engineering, and regenerative medicine using bioresorbable polymers. Their integration eliminates the need for multiple procedures and greatly improves patient functional performance. There are numerous advancements in polymer science, along with flexible regulatory timelines, that promise bioresorbable polymers as a development focus.
Recent Market Developments:
A considerable number of strategic alliances, market development, etc., have been performed over the past few years:
- In 2024, Evonik Industries AG increased the capacity of its RESOMER bioresorbable polymer production facilities in Germany and opened a new plant to respond to growing requests for medical-grade fixation, stents, and other stents used in drug delivery systems. Evonik Industries is strengthening its global leadership position in medical polymers.
- In 2022, Corbion N.V. Advanced a new range of high-purity 'polylactic acids' (PLA) for bioresorbable sutures and implants with improved mechanical strength, controlled degradation rates, and other functionalities to support next-gen medical device applications.
Recent JVs, acquisitions, mergers:
- In 2022, DSM Biomedical and Xilloc Medical, a company focused on PCL-based biomaterials, entered into a strategic partnership for the development of bioresorbable scaffolds used in regenerative medicine for tissue repair and bone healing. The partnership aims to combine biomaterials engineering with 3D printing and other technologies.
- In 2024, Ashland Global Holdings Inc. purchased the bioresorbable polymer division of Seqens SAS for the purpose of reinforcing its specialty medical polymer division. This purchase strengthens Ashland's position in advanced drug delivery and surgical systems due to growing demand in the US and Europe.
Segments Analysis
|
Segmentations
|
List of Sub-Segments
|
Segments with High-Growth Opportunity
|
|
Type Analysis
|
Polylactic acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-glycolic acid (PLGA), Polycaprolactone (PCL)
|
Polycaprolactone (PCL) is the fastest-growing segment because its biocompatibility, slow degradation, and mechanical strength make it ideal for tissue engineering, regenerative medicine, and long-term implants, driving faster adoption than PLA, PGA, or PLGA.
|
|
Application Analysis
|
Orthopedic Devices and Drug Delivery
|
Drug delivery is the fastest-growing segment because bioresorbable polymers enable controlled release, improved bioavailability, and eliminate the need for device removal, making them increasingly preferred in advanced therapeutics compared to orthopedics, sutures, or stents.
|
|
Region Analysis
|
North America, Europe, Asia-Pacific, and The Rest of the World
|
Asia-Pacific is the dominant region for large-scale natural refrigerant heat pumps because booming infrastructure development, aggressive government investments in green technologies, and rapid industrialization are supercharging adoption.
|
By Refrigerant
“Polylactic Acid (PLA) is the largest type of segment because of its wide availability, cost-effectiveness, and long-standing use in medical applications such as orthopedic implants and sutures.”
Polylactic Acid (PLA) is the largest type of segment because of its widespread availability, cost-effectiveness, and established use in medical devices such as orthopedic fixation products and sutures. PLA dominates the market due to its favourable mechanical properties, biocompatibility, and proven track record in regulated healthcare applications. As a versatile material with reliable performance, it remains the preferred choice for large-scale commercial adoption where safety, effectiveness, and accessibility are critical.
By Capacity Analysis
“Orthopedics is the dominant and fastest-growing application segment because it combines high clinical demand, patient benefits, and suitability for a wide range of temporary implant and fixation applications.”
Orthopedics is the dominant application category because it represents the largest use of bioresorbable polymers in fixation devices, screws, pins, and plates that provide temporary support and safely degrade in the body. Orthopedic applications lead the market as they address widespread conditions like fractures and sports injuries, reducing the need for secondary surgeries and improving patient recovery outcomes. With rising aging populations and higher incidence of bone-related disorders, orthopedics continues to anchor demand while newer applications like drug delivery and stents are expanding at a faster pace
Regional Analysis
“Asia-Pacific is the most rapidly growing market for bioresorbable polymers, fuelled by rising healthcare investment, expanding medical tourism, and swift adoption of advanced medical devices.”
Asia-Pacific is the fastest-growing market for bioresorbable polymers, driven by rising healthcare spending, expanding medical tourism, and rapid adoption of advanced medical devices. China, India, and Southeast Asian countries are increasingly investing in modern hospitals, regulatory support, and innovative treatments, accelerating the use of bioresorbable implants and drug delivery systems.
Key Players
The market is moderately fragmented, with over 80 players. Most of the major players compete in some of the governing factors, including price, service offerings, and regional presence, etc. The following are the key players in the bioresorbable polymers market.
Here is the list of the Top Players (Based on Dominance)
- Corbion N.V.
- Evonik Industries AG
- DSM Biomedical
- Poly-Med Inc
- Ashland Global Holdings Inc.
- KLS Martin Grou
- Foster Corporation
- Zeus Industrial Products Inc.
- SEQENS SAS
- Reva Medical LLC
Note: The above list does not necessarily include all the top players in the market.
Are you the leading player in this market? We would love to include your name. Please write to us at sales@stratviewresearch.com
Report Features
This report provides market intelligence most comprehensively. The report structure has been kept so that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market. The following are the key features of the report:
- Market structure: Overview, industry life cycle analysis, supply chain analysis.
- Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
- Market trend and forecast analysis.
- Market segment trend and forecast.
- Competitive landscape and dynamics: Market share, Service portfolio, New Product Launches, etc.
- COVID-19 impact and its recovery curve.
- Attractive market segments and associated growth opportunities.
- Emerging trends.
- Strategic growth opportunities for the existing and new players.
- Key success factors.
The global bioresorbable polymers market is segmented into the following categories.
Bioresorbable Polymers Market, by Type
- Polylactic acid (PLA) (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
- Polyglycolic Acid (PGA) (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
- Polylactic-co-glycolic acid (PLGA) (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
- Polycaprolactone (PCL) (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
Bioresorbable Polymers Market, by Application
- Orthopedic Devices (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
- Drug Delivery (Regional Analysis: North America, Europe, Asia-Pacific, and Rest of the World)
Bioresorbable Polymers Market by Region
- North America (Country Analysis: The USA, Canada, and Mexico)
- Europe (Country Analysis: Germany, France, The UK, Russia, and the Rest of Europe)
- Asia-Pacific (Country Analysis: China, India, Japan, and Rest of Asia-Pacific)
- Rest of the World (Country Analysis: Brazil, Saudi Arabia, and Others)
Research Methodology
- This strategic assessment report from Stratview Research provides a comprehensive analysis that reflects today’s bioresorbable polymers market and future market possibilities for the forecast period.
- The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market.
- The vital data/information provided in the report can play a crucial role for market participants and investors in identifying the low-hanging fruit available in the market and formulating growth strategies to expedite their growth process.
- This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
- More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.
- We conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights
Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respected clients:
Company Profiling
- Detailed profiling of additional market players (up to three players)
- SWOT analysis of key players (up to three players)
Competitive Benchmarking
- Benchmarking of key players on the following parameters: Service portfolio, geographical reach, regional presence, and strategic alliances
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com
